ZHU Li, ZOU Xuan, LIU Tang-rong, LIU Ruo-nan, XU Zhe. Recent advances in enzyme inhibitor screening based on mass spectrometryJ. Acta Pharmaceutica Sinica, 2019,54(5): 818-827. doi: 10.16438/j.0513-4870.2018-1132
Citation: ZHU Li, ZOU Xuan, LIU Tang-rong, LIU Ruo-nan, XU Zhe. Recent advances in enzyme inhibitor screening based on mass spectrometryJ. Acta Pharmaceutica Sinica, 2019,54(5): 818-827. doi: 10.16438/j.0513-4870.2018-1132

Recent advances in enzyme inhibitor screening based on mass spectrometry

  • Enzymes play crucial functional roles in all biological processes. Enzymatic inhibitors can regulate enzyme activity and may become the starting point for drug discovery. Mass spectrometry (MS) has the advantage for rapid qualitative and quantitative analyses of compounds and enzyme reactions, emerging as an important analytical tool in enzyme inhibitor screening assay for drug discovery. This review will highlight recent advances in the inhibitor screening assay using MS and related techniques, including frontier affinity chromatography, immobilized enzyme beads, ultrafiltration, surface plasmon resonance, capillary electrophoresis and microfluidic chips. The existing MS methods for screening enzyme inhibitor were divided into two types:affinity screening and activity screening.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return